Adagio Medical
NASDAQ: ADGMLaguna Hills, US · Delaware corporation · 1 known investors
Find your way into Adagio Medical
1,062 people in our graph share verified history with the Adagio Medical team — schools, employers, funds. One of them is your warm intro.
Adagio Medical develops and commercializes catheter-based cardiac ablation devices using proprietary Ultra-Low Temperature Ablation (ULTA) technology to treat ventricular tachycardia and other cardiac arrhythmias. The company's vCLAS Cryoablation System, which has received CE Mark approval in Europe and is undergoing FDA review, is designed to create large, durable lesions in heart muscle tissue to address abnormal electrical pathways in patients with structural heart disease and idiopathic arrhythmias.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$79.1M disclosed across 5 rounds · 2014–2022
▶$9.5MraisedNov 2022 · 6 investors · Other Health CareRule 506(b)
- James CoxDirector
- Tuan HuynhDirector
- Andrew WadeExecutive Officer
- Michael ZhaoDirector
- Olav BergheimExecutive Officer, Director
- Zach ScheinerDirector
- Offering amount
- $10M
- Amount sold
- $9.5M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42.5MraisedNov 2020 · 16 investors · Other Health CareRule 506(b)
- Michael ZhaoDirector
- Zach ScheinerDirector
- Tuan HuynhDirector
- James CoxDirector
- Andrew WadeExecutive Officer
- Olav BergheimExecutive Officer, Director
- Offering amount
- $42.5M
- Amount sold
- $42.5M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedApr 2019 · 7 investors · Other Health CareRule 506(b)
- Andrew WadeExecutive Officer
- Michael ZhaoDirector
- Olav BergheimExecutive Officer, Director
- James CoxDirector
- Offering amount
- $20M
- Amount sold
- $7M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedOct 2018 · 11 investors · Other Health CareRule 506(b)
- Hugh NeuharthExecutive Officer
- Michael ZhaoDirector
- James CoxDirector
- Olav BergheimExecutive Officer, Director
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedAug 2014 · 6 investors · Other Health CareRule 506(b)
- Olav BergheimExecutive Officer, Director
- Hugh NeuharthExecutive Officer
- Offering amount
- $6M
- Amount sold
- $4.1M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Adagio Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adagio Medical do?
- Adagio Medical develops and commercializes catheter-based cardiac ablation devices using proprietary Ultra-Low Temperature Ablation (ULTA) technology to treat ventricular tachycardia and other cardiac arrhythmias. The company's vCLAS Cryoablation System, which has received CE Mark approval in Europe and is undergoing FDA review, is designed to create large, durable lesions in heart muscle tissue to address abnormal electrical pathways in patients with structural heart disease and idiopathic arrhythmias.
- Who founded Adagio Medical?
- Adagio Medical was founded by Olav Bergheim.
- Who are Adagio Medical's investors?
- Adagio Medical's investors include RA Capital.
- How much funding has Adagio Medical raised?
- Adagio Medical has disclosed $79.1M raised across 5 rounds.
- Where is Adagio Medical headquartered?
- Adagio Medical is headquartered in Laguna Hills, US.